Have We Learned How to Talk About GLP1s?
We talk about how people navigate conversations around GLP-1s.
April 28, 2026
54 min
Full
3,313 of 3,393
April 28, 2026
Have We Learned How to Talk About GLP1s?
0:00 / 54:46
Excerpt playback isn’t available for this episode — use the full-episode link.
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
America the Jesuit Review Episodes Around April 28, 2026
Episode 3,313 of 3,393 — walk the feed in the order it was published.
Have We Learned How to Talk About GLP1s?
Summary
An estimated one in eight Americans has now tried a GLP-1 medication like Ozempic or WeGovy: to lose weight, manage diabetes or experiment with anecdotal, off-label benefits. Yet GLP-1s can be hard to talk about — whether you want to ask someone if they take one, respond if you do, or discuss weight without dredging up unhealthy diet discourse. We’ll hear how you’re navigating these conversations in the age of GLP-1s. Tell us: How are GLP-1s showing up in your world?
Guests:
Diana Thiara, medical director, UCSF Weight Loss Management Program
Whitney Casares, pediatrician; author, “Raising Body-Confident Kids” and “My One-Of A-Kind Body: The Ultimate Guide to Caring for Me”
Angela Corral, senior editor, KQED’s The California Report; she has been been taking a GLP-1 for almost 2 years
Learn more about your ad choices. Visit megaphone.fm/adchoices
Episode details and artwork are published by the show’s own feed. Sentinel plays short cited excerpts and links every episode back to its publisher.